help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blomhoff, A.
Right arrow Articles by Undlien, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blomhoff, A.
Right arrow Articles by Undlien, D. E.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Medline Plus Health Information
*Addison's Disease
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 7 3474-3476
Copyright © 2004 by The Endocrine Society

Polymorphisms in the Cytotoxic T Lymphocyte Antigen-4 Gene Region Confer Susceptibility to Addison’s Disease

Anne Blomhoff, Benedicte A. Lie, Anne G. Myhre, E. Helen Kemp, Anthony P. Weetman, Hanne E. Akselsen, Eystein S. Huseby and Dag E. Undlien

Institute of Medical Genetics (A.B., H.E.A., D.E.U.), Ullevål University Hospital, University of Oslo, 0315 Oslo, Norway; Institute of Immunology (B.A.L.), Rikshospitalet University Hospital, 0027 Oslo, Norway; Departments of Paediatrics and Clinical Molecular Biology (A.G.M.), Akershus University Hospital, 1474 Nordbyhagen, Norway; Division of Clinical Sciences (North) (E.H.K., A.P.W.), University of Sheffield, Sheffield S5 7AU, United Kingdom; and Division of Endocrinology, Institute of Medicine (E.S.H.), Haukland University Hospital, N-5021 Bergen, Norway

Address all correspondence and requests for reprints to: Dr. Anne Blomhoff, Institute of Medical Genetics, University of Oslo, P.O. Box 1036, Blindern, NO-0315 Oslo, Norway. E-mail: anne.blomhoff{at}ioks.uio.no.

The cytotoxic T lymphocyte antigen-4 (CTLA4) gene on chromosome 2q33 encodes a key regulator in the adaptive immune system. The CTLA4 surface molecule is expressed on activated T lymphocytes and involved in down-regulation of the immune response. Previous studies on a possible association between autoimmune Addison’s disease and CTLA4 polymorphisms have shown conflicting results. A recent study identified new candidate polymorphisms in the CTLA4 region, influencing gene splicing and thereby the relative abundance of soluble CTLA4. We genotyped 134 patients with Addison’s disease and 413 healthy controls from Norway and United Kingdom for these newly identified polymorphisms. Our data demonstrate that the same polymorphisms that have recently been demonstrated to confer susceptibility to autoimmune thyroid disease and type 1 diabetes also confer susceptibility to Addison’s disease. This finding suggests that polymorphisms in CTLA4 confer general risk to develop autoimmunity and identifies a potential therapeutic target in the prevention of autoimmune endocrine disorders.

This work was supported by University of Oslo, Norwegian Diabetes Association, Novo Nordisk Research Foundation, Norwegian Research Council, Haukeland University Hospital, and Innovest.

Abbreviations: APS, Autoimmune polyendocrine syndrome; CTLA4, cytotoxic T lymphocyte antigen-4; HLA, histocompatibility leukocyte antigen; SNP, single nucleotide polymorphism.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
B. Skinningsrud, E. S. Husebye, S. H. Pearce, D. O. McDonald, K. Brandal, A. B. Wolff, K. Lovas, T. Egeland, and D. E. Undlien
Polymorphisms in CLEC16A and CIITA at 16p13 Are Associated with Primary Adrenal Insufficiency
J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3310 - 3317.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. M. Maier, D. E. Anderson, P. L. De Jager, L. S. Wicker, and D. A. Hafler
Allelic variant in CTLA4 alters T cell phosphorylation patterns
PNAS, November 20, 2007; 104(47): 18607 - 18612.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
D.S. C. Graham, A.K. Wong, N.J. McHugh, J.C. Whittaker, and T. J. Vyse
Evidence for unique association signals in SLE at the CD28-CTLA4-ICOS locus in a family-based study
Hum. Mol. Genet., November 1, 2006; 15(21): 3195 - 3205.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. A. Aly, A. Ide, M. M. Jahromi, J. M. Barker, M. S. Fernando, S. R. Babu, L. Yu, D. Miao, H. A. Erlich, P. R. Fain, et al.
Extreme genetic risk for type 1A diabetes
PNAS, September 19, 2006; 103(38): 14074 - 14079.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society